Trump Admin Ends Medicare Drug Plan Subsidies
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Trump administration will end subsidies for private Medicare drug plans, likely resulting in higher premiums for some older adults right before the midterm elections.
- Democrats were already campaigning on the approximately $1 trillion in health care cuts in Republicans' tax bill from last summer and immediately seized on the subsidy decision as another opportunity to attack Republicans on affordability.
- Senate Minority Leader Chuck Schumer (D-N.Y.) called the decision "heartless, cruel, and completely by choice."
- The subsidy change gives Democrats a concrete, timing-specific example of GOP-driven cost increases heading into the midterm campaign.
Why it matters: With the decision landing right before midterm elections and on top of the approximately $1 trillion in health care cuts Democrats were already highlighting, the subsidy end creates a concrete affordability story for vulnerable older voters — Schumer's sharp response underscores the partisan stakes baked into the timing.
